![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: UHRF1BP1 |
Gene summary for UHRF1BP1 |
![]() |
Gene information | Species | Human | Gene symbol | UHRF1BP1 | Gene ID | 54887 |
Gene name | UHRF1 binding protein 1 | |
Gene Alias | C6orf107 | |
Cytomap | 6p21.31 | |
Gene Type | protein-coding | GO ID | GO:0003674 | UniProtAcc | Q6BDS2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
54887 | UHRF1BP1 | HCC1_Meng | Human | Liver | HCC | 2.71e-47 | 1.14e-01 | 0.0246 |
54887 | UHRF1BP1 | HCC1 | Human | Liver | HCC | 1.14e-17 | 3.13e+00 | 0.5336 |
54887 | UHRF1BP1 | HCC2 | Human | Liver | HCC | 3.55e-11 | 2.83e+00 | 0.5341 |
54887 | UHRF1BP1 | HCC5 | Human | Liver | HCC | 2.44e-07 | 2.35e+00 | 0.4932 |
54887 | UHRF1BP1 | S014 | Human | Liver | HCC | 8.20e-04 | 3.13e-01 | 0.2254 |
54887 | UHRF1BP1 | S015 | Human | Liver | HCC | 5.07e-05 | 3.43e-01 | 0.2375 |
54887 | UHRF1BP1 | S016 | Human | Liver | HCC | 8.51e-04 | 2.95e-01 | 0.2243 |
54887 | UHRF1BP1 | S027 | Human | Liver | HCC | 5.19e-04 | 4.61e-01 | 0.2446 |
54887 | UHRF1BP1 | S028 | Human | Liver | HCC | 3.48e-14 | 5.54e-01 | 0.2503 |
54887 | UHRF1BP1 | S029 | Human | Liver | HCC | 1.33e-07 | 4.72e-01 | 0.2581 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Liver | ![]() | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
UHRF1BP1 | SNV | Missense_Mutation | novel | c.4010N>T | p.Ser1337Phe | p.S1337F | Q6BDS2 | protein_coding | deleterious(0) | probably_damaging(0.957) | TCGA-HM-A4S6-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR |
UHRF1BP1 | SNV | Missense_Mutation | novel | c.4141N>G | p.Gln1381Glu | p.Q1381E | Q6BDS2 | protein_coding | tolerated(0.77) | benign(0.039) | TCGA-HM-A4S6-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR |
UHRF1BP1 | SNV | Missense_Mutation | novel | c.290N>T | p.Pro97Leu | p.P97L | Q6BDS2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
UHRF1BP1 | SNV | Missense_Mutation | c.3445N>G | p.Leu1149Val | p.L1149V | Q6BDS2 | protein_coding | tolerated(0.26) | benign(0) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
UHRF1BP1 | SNV | Missense_Mutation | c.340G>A | p.Glu114Lys | p.E114K | Q6BDS2 | protein_coding | deleterious(0) | probably_damaging(0.96) | TCGA-LP-A4AV-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
UHRF1BP1 | SNV | Missense_Mutation | c.2510N>A | p.Ala837Asp | p.A837D | Q6BDS2 | protein_coding | deleterious(0.01) | possibly_damaging(0.866) | TCGA-A6-3809-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
UHRF1BP1 | SNV | Missense_Mutation | rs752440185 | c.3271N>A | p.Ala1091Thr | p.A1091T | Q6BDS2 | protein_coding | tolerated(0.23) | benign(0.1) | TCGA-A6-5661-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
UHRF1BP1 | SNV | Missense_Mutation | c.812G>A | p.Arg271Lys | p.R271K | Q6BDS2 | protein_coding | deleterious(0.01) | probably_damaging(0.994) | TCGA-A6-5662-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | PD | |
UHRF1BP1 | SNV | Missense_Mutation | rs765402544 | c.427G>A | p.Ala143Thr | p.A143T | Q6BDS2 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-A6-5665-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
UHRF1BP1 | SNV | Missense_Mutation | rs772647195 | c.1426N>T | p.His476Tyr | p.H476Y | Q6BDS2 | protein_coding | tolerated(0.55) | benign(0.148) | TCGA-AA-3695-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |